Isotretinoin iPLEDGE REMS Proposed Revisions To Get Two-Day AdComm Review

 
• By Brenda Sandburg
  
Isotretinoin
FDA panel to discuss proposed changes to the Risk Evaluation and Mitigation Strategy for isotretinoin • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers